Impact of genetic variation of tumor necrosis factor-α on gestational hypertension

Chinese Medical Journal

Volumn 119, Issue 9, 2006, Pages 719-724

  Chen, You Peng ^a   Pfab, Thiemo ^b   Slowinski, Torsten ^b   Richter, Claus Michael ^b   Godes, Michael ^b   Hocher, Berthold ^b  

^a JINAN UNIVERSITY   (China)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Gestational hypertension; Polymorphism; Preeclampsia; Restriction fragment length; Tumor necrosis factor

Indexed keywords

HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD PRESSURE REGULATION; CHROMOSOME 6; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PATHOGENESIS; PREECLAMPSIA; PROMOTER REGION; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE; TH1 CELL; THIRD TRIMESTER PREGNANCY; URINARY EXCRETION;

EID: 33744477344     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200605010-00003     Document Type: Article

References (20)

1. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001; 38:718-722.
2. Hajeer AH, Hutchinson IV. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 2001; 62:1191-1199.
3. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992; 1:353.
4. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94: 3195-3199.
5. Wilson AG, De Vries N, Pociot F, di Giovine FS, van der Putte LB, Doff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560.
6. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104:154-159.
7. Dizon-Townson DS, Major H, Ward K. A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia. J Reprod Immunol 1998; 38: 55-61.
8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
9. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318:1332-1336.
10. Walker JJ. Pre-eclampsia. Lancet 2000; 356: 1260-1265.
11. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102:181-192.
12. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-1757.
13. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996; 32:157-169.
14. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 1999; 41:297-306.
15. Serin IS, Ozcelik B, Bapbuo M, Kylyc H, Okur D, Erez R. Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2002; 100: 143-145.
16. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181: 915-920.
17. Dong M, He J, Wang Z, Xie X, Wang H. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta Obstet Gynecol Scand 2005; 84: 788-793.
18. Poli F, Boschiero L, Giannoni F, Tonini M, Scalamogna M, Ancona G, et al. Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation. Cytokine 2000; 12:1778-1783.
19. Aidoo M, McElroy PD, Kolczak MS, Terlouw DJ, ter Kuile FO, Nahlen B, et al. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol 2001; 21: 201-211.
20. Reid JG, Simpson NA, Walker RG, Economidou O, Shillito, J, Gooi HC, et al. The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 2001; 45: 35-40.